PFSA

Profusa Inc

Jun 01 • 04:00PM ET

0.3424

0.0000 0.00 %

Healthcare • Medical Devices • USA • Nano • NASD

Peers: IVF NUWE VTAK AEMD AMIX HSCS INBS XAIR NXL TNON

Index	-	P/E	-	EPS (ttm)	-179.82	Insider Own	1.36%	Shs Outstand	4.66M	Perf Week	-8.98%
Market Cap	1.60M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.60M	Perf Month	-42.55%
Enterprise Value	13.76M	PEG	-	EPS next Q	-	Inst Own	1.56%	Short Float	5.84%	Perf Quarter	-64.95%
Income	-42.41M	P/S	-	EPS this Y	-	Inst Trans	1.10%	Short Ratio	0.06	Perf Half Y	-97.15%
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-2980.89%	Short Interest	0.27M	Perf YTD	-95.64%
Book/sh	-11.85	P/C	4.21	EPS next 5Y	-	ROE	-	52W High	938.25 -99.96%	Perf Year	-99.96%
Cash/sh	0.08	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	0.33 3.35%	Perf 3Y	-99.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.46% 8.90%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-53.06%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.02	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	31.59	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.02	EPS Q/Q	87.34%	SMA20	-20.27%	Beta	4.51	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-42.16%	Rel Volume	0.00	Prev Close	0.34
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	-96.89%	Avg Volume	4.74M	Price	0.34
IPO	Jan 24, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	0	Change	0.00%

May-15-26 07:30AM	Profusa Announces Listing Transfer to The Nasdaq Capital Market (GlobeNewswire)
May-08-26 06:00AM	Profusa Receives Favorable Nasdaq Listing Determination (GlobeNewswire) +5.27%
May-05-26 08:30AM	Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value (GlobeNewswire) -6.64%
Apr-28-26 10:30AM	BC-Most Active Stocks (Associated Press) +8.22%
Apr-06-26 10:30AM	BC-Most Active Stocks (Associated Press) +144.06%
06:00AM	Loading…
06:00AM	Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform (GlobeNewswire)
Feb-27-26 09:15AM	Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering (GlobeNewswire) -14.75%
Feb-19-26 08:30AM	Profusa Receives Purchase Orders for Lumee Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance (GlobeNewswire)
Feb-13-26 08:30AM	Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies (GlobeNewswire) -33.44%
Feb-12-26 04:30PM	Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies (GlobeNewswire)
Feb-05-26 08:00AM	Profusa Announces 1-for-75 Reverse Stock Split (GlobeNewswire) -36.35%
Jan-29-26 08:00AM	Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026 (GlobeNewswire)
Jan-16-26 12:51PM	Profusa Stock Spikes As Lumee System Targets Research Market (Benzinga)
07:30AM	Profusa Launches Lumee Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue (GlobeNewswire)
Jan-08-26 07:30AM	Profusa Adds Leading Greek Vascular Surgeon to Customer Base (GlobeNewswire)
07:30AM	Loading…
Dec-31-25 07:30AM	Profusa Bolsters European Commercial Network with New French Distributor, MedSell (GlobeNewswire) -13.96%
Dec-30-25 07:30AM	Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 (GlobeNewswire) +78.33%
Dec-15-25 07:30AM	Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 (GlobeNewswire) -19.87%
Dec-11-25 08:30AM	Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 (GlobeNewswire)
Nov-24-25 08:15AM	Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 (GlobeNewswire) +8.38%
Nov-19-25 05:44PM	Profusa Announces Third Quarter Business and Financial Highlights (GlobeNewswire) -5.95% -19.59%
Oct-30-25 07:30AM	Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee Oxygen and Glucose Monitoring Launches (GlobeNewswire) -9.85%
Oct-28-25 08:30AM	Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 (GlobeNewswire)
Oct-22-25 08:30AM	Profusa Expands Sales Footprint with New Distributor for Lumee Oxygen Platform in Europe (GlobeNewswire) -8.11%
Oct-15-25 08:30AM	Profusa Expands Sales Footprint with New Distributor for Lumee Oxygen Platform in Europe (GlobeNewswire)
Oct-07-25 08:15AM	Profusa Invests Additional $1 Million in Digital Treasury Assets (GlobeNewswire)
Oct-01-25 08:30AM	Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base (GlobeNewswire)
Sep-11-25 08:45AM	Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform (PR Newswire) +74.04%
08:30AM	Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring (GlobeNewswire)
Sep-04-25 08:30AM	Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base (GlobeNewswire) -7.94%
04:05PM	Loading…
Sep-02-25 04:05PM	Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire) -7.83% -5.00%
Aug-27-25 08:45AM	Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria (GlobeNewswire)
Aug-19-25 08:15AM	Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO (GlobeNewswire) -7.99%
Aug-06-25 08:15AM	Profusa, Inc. Provides Strategy Overview and Business Update for Investors (GlobeNewswire) -7.72%
Jul-31-25 08:15AM	Profusa Secures Lumee Oxygen Platform Distributor in Spain (GlobeNewswire)
Jul-30-25 08:00AM	Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy (GlobeNewswire) -17.80%
Jul-21-25 08:00AM	Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy (GlobeNewswire) -17.32%
Jul-11-25 04:00PM	Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq (GlobeNewswire) -80.02% -19.20%

Profusa, Inc. engages in the biofeedback for chronic disease management and healthy living services. The company is founded by Natalie Wisniewski and Bill McMillan and is headquartered in Berkeley, CA.

Chief Financial OfficerMr. Fred S. Knechtel

Co-founderMr. William McMillan

Head of Digital Health BusinessMr. David Icke

Head of Government BusinessMr. Sean Givens

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFSA

Profusa Inc

Upgrade your Finviz experience